Vitamin D requirement and setting recommendation levels: Long-term perspectives

Nutrition Reviews

Volumn 66, Issue SUPPL.2, 2008, Pages

  Mosekilde, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

25 hydroxyvitamin D; Recommendations; Requirements; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; VITAMIN D;

AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIAGNOSTIC VALUE; DIETARY INTAKE; DISEASE ASSOCIATION; FALLING; FOOD INTAKE; FRACTURE; HUMAN; HYPERPARATHYROIDISM; INTESTINE ABSORPTION; MYOPATHY; NUTRITIONAL REQUIREMENT; OSTEOMALACIA; PREVENTION; RICKETS; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE;

BIOLOGICAL AVAILABILITY; BONE DENSITY CONSERVATION AGENTS; HUMANS; INTESTINAL ABSORPTION; NUTRITION POLICY; NUTRITIONAL REQUIREMENTS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 52649167721     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00103.x     Document Type: Conference Paper

References (72)

1. Vieth R. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol. 2004 89 90: 575 579.
2. Holick MF. Evolution and function of vitamin D. Recent Res Cancer Res. 2003 164: 3 28.
3. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr. 2005 135: 310 316.
4. Iqbal SJ, Kaddam I, Wassif W, Nichol F, Walls J. Continuing clinically severe vitamin D deficiency in Asians in the UK (Leicester). Postgrad Med J. 1994 70: 708 714.
5. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002 76: 187 192.
6. Harris SS. Vitamin D and African Americans. J Nutr. 2006 136: 1126 1129.
7. Rejnmark L, Jorgensen ME, Pedersen MB, et al. Vitamin D insufficiency in Greenlanders on a westernized fare. Ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcif Tissue Int. 2004 74: 255 263.
8. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001 22: 477 501.
9. Bischoff HA, Stahelin HB, Tyndall A, Theiler R. Relationship between muscle strength and vitamin D metabolites: are there therapeutic possibilities in the elderly? Z Rheumatol. 2000 59 (Suppl 1 39 41.
10. Stein MS, Wark JD, Scherer SC, et al. Falls related to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc. 1999 47: 195 201.
11. Pfeifer M, Begerow B, Minne HW, et al. Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes. 2001 109: 87 92.
12. Dhesi JK, Bearne LM, Moniz C, et al. Neuromuscular and psychomotor function in elderly people who fall and the relationship with vitamin D status. J Bone Miner Res. 2002 17: 891 897.
13. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004 291: 1999 2006.
14. Ooms ME, Lips P, Roos JC, et al. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res. 1995 10: 1177 1184.
15. Jesudason D, Need AG, Horowitz M, et al. Relationship between serum 25- hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone. 2002 31: 626 630.
16. Lips P, van Ginkel FC, Jongen MJ, et al. Determinants of vitamin D status in patients with hip fracture and elderly control subjects. Am J Clin Nutr. 1987 46: 1005 1010.
17. Boonen S, Vanderschueren D, Cheng XG, et al. Age related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D and androgen deficiency induced bone resorption. J Bone Miner Res. 1997 12: 2119 2126.
18. Gillespie WJ, Avenell A, Henry DA, et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (Cochrane Review) I. The Cochrane Library, issue 1. Update Software, Oxford, 2003.
19. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf). 2005 62: 265 281.
20. Muhe L, Lulseged S, Mason KE, Simoes EAF. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet. 1997 349: 1801 1804.
21. Chan TY. Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int. 2000 66: 476 478.
22. Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr. 2004 80: 108 113.
23. Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab. 2005 16: 261 266.
24. Merlino LA, Curtis J, Mikuls TR, et al. Vitamin D intake is inversely associated with rheumatoid arthritis. Arthritis Rheum. 2004 50: 72 77.
25. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 1991 324: 928 1016.
26. Jahnsen J, Falch JA, Mowinckel ZP, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002 37: 192 197.
27. Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc. 2000 59: 531 535.
28. Van der Mei IA, Ponsonby AL, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case control study. BMJ. 2003 327: 216.
29. Pfeifer M, Begerow B, Minne HW, et al. Effect of short-term vitamin D and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001 86: 1633 1637.
30. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997 30: 150 156.
31. Lind L, Lithell H, Skarfors E, et al. Reduction of blood pressure by treatment with alfacalcidiol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Med Scand. 1988 223: 211 227.
32. Krause R, Buhring M, Hopfenmühller W, et al. Ultraviolet B and blood pressure. Lancet. 1998 352: 709 710.
33. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005 94: 483 492.
34. Moosgaard B, Vestergaard P, Heickendorff L, et al. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf). 2005 63: 506 513.
35. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006 84: 18 28.
36. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005 135: 317 322.
37. Zehnder D, Bland R, Williams MC, et al. Extrarenal expression of 25-hydroxyvitamin D3-1alphahydroxylase. J Clin Endocrinol Metab. 2001 86: 888 894.
38. Lips P, Chapuy MC, Dawson-Hughes B, Pols HAP, et al. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporosis Int. 1999 9: 394 397.
39. Lauridsen AL, Vestergaard P, Herman AP, et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int. 2005 77: 15 22.
40. Rejnmark L, Lauridsen A, Brot C, et al. Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest. 2006 66: 227 238.
41. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet radiation. Lancet. 1989 4: 1104 1105.
42. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000 72: 690 693.
43. Snijder MB, van Dam RM, Visser M, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab. 2005 90: 4119 4123.
44. Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004 89: 1196 1199.
45. Zierold C, Mings JA, DeLuca HF. Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone. J Cell Biochem. 2003 88: 234 237.
46. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes D. Fracture prevention with vitamin D supplementation. A meta-analysis of randomized controlled trials. JAMA. 2005 293: 1257 1264.
47. Ovesen L, Andersen R, Jakobsen J. Geographical differences in vitamin D status with particular reference to European countries. Proc Nutr Soc. 2003 62: 813 821.
48. Brot C, Vestergaard P, Kolthoff N, et al. Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr. 2001 86 (Suppl S97 S103.
49. Pfeifer M, Begerow B, Mine HW, Abrams C, Nachtigall D, Hansen C. Effects of short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res. 2000 15: 1113 1118.
50. Bischoff HA, Stähelin HB, Dick W, et al. Effect of vitamin D and calcium supplementation on falls: a randomized controlled study. J Bone Miner Res. 2003 18: 343 351.
51. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999 69: 842 856.
52. Vieth R, Chan P-CR, Mac Farlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2003 73: 288 294.
53. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003 77: 204 210.
54. Muskiet FA, Dijck-Brouwer DA, van der Veer E, Schaafsma A. Do we really need > or =100 μg vitamin D/d, and is it safe for all of us? Am J Clin Nutr. 2001 74: 862 864.
55. Lamberg-Allardt C. Vitamin D in food and its supplements. Prog Biophys Mol Biol. 2006 92: 33 38.
56. Alexander J, Aro A, Andersen NL, et al Nordic Nutrition Recommendations 2004. Nordic Council of Ministers, Copenhagen. Available at: http://www.norden.org/pub/velfaerd/livsmedel/sk/N2004013.pdf (in Danish). Accessed 2 September 2008.
57. Erbersdobler H, Elmadfa I, Keller U, Walter P. Referenzwerte für die Nährstoffzufuhr. Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerchen Vereinigung für Ernährung. Frankfurt am Main: Umschau/ Braus 2000. Available at: http://www.dge.de/pdf/ws/ReferenceValues.pdf. Accessed 2 September 2008.
58. Printice A, Aggett PJ, Bolton-Smith C, et al. Nutrition and Bone Health: with Particular Reference to Calcium and Vitamin D. Report of the Subgroup on Bone Health, Working Group on the Nutritional Status of the Population of the Committee on Medical Aspects of Food and Nutrition Policy. London: The Stationery Office 1998
59. Young V, Garza C. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutritional Board, Institute of Medicine. Washington DC: National Academy Press 1997
60. Cumming C, Gopalan C, Hallberg L, et al. Human Vitamin and Mineral Requirements. Report of a Joint FAO/WHO Expert Consultation, Bangkok. Thailand. Rome: Food and Nutrition Division, FAO 2001.
61. Prentice A. What are the dietary requirements for calcium and vitamin D? Calcif Tissue Int. 2002 70: 83 88.
62. Dawson-Hughes B. Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women. Am J Clin Nutr. 2004 80 (Suppl S1763 S1766.
63. Danish Institute for Food and Veterinary Research (2004). Vitamin D Status in the Danish Population Should be Improved (in Danish with English summary). Available at: http://www.dfvf.dk/Default.aspx?ID=10082. Accessed 2 September 2008.
64. Blank S, Scanlon KS, Sinks TH, Lett S, Falk H. An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. Am J Public Health. 1995 85: 656 659.
65. Scanlon KS, Blank S, Sinks T, et al. Subclinical health effects in a population exposed to excess vitamin D in milk. Am J Public Health. 1995 85: 1418 1422.
66. Scientific Committee on Food. Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Vitamin D. SCF/YCS/NUT/UPPLEV/38 Final. Brussels: The European Commission 2002. Available at: http://ec.europa.eu/food/ fs/sc/scf/out157_en.pdf. Accessed 2 September 2008.
67. Heikinheimo RJ, Inkovaara JA, Harju EJ, et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int. 1992 51: 105 110.
68. Smith H, Anderson F, Raphael H, et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women - a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 2007 46: 1852 1857.
69. Stephens WP, Klimiuk PS, Berry JL, Mawer EB. Annual high-dose vitamin D prophylaxis in Asian immigrants. Lancet. 1981 28: 1199 1202.
70. Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2005 3: CD000227.
71. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementations on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003 326: 469 475.
72. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr. 2007 85: 6 18.